The move comes nearly 35 years after the dye was barred from cosmetics such as lipsticks because of potential cancer risk.

The FDA banned the use of red dye No. 3 in foods and medicines sold in the U.S. because it has been shown to cause cancer in ...

The US Food and Drug Administration has banned the use of red dye No. 3 in food and ingested drugs, more than 30 years after ...

The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, ...

The proposed "Nutrition info box" would show customers whether products have low, medium or high levels of saturated fat, ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.

European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy ...

The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.

The key lies in adopting proven strategies that focus on sustainable lifestyle changes rather than quick fixes. A well-balanced diet combined with regular exercise and stress management are essential ...

After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug Opdivo Qvantig’s average administration time of less than five minutes was observed in the Checkmate ...